Antibiotic Combo Approved for Multidrug-Resistant UTIs

Published Date: 06 Jul 2026

Intravenous cefepime-zidebactam was significantly superior to meropenem in phase III trial

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In patients with prostate cancer, second-generation antiandrogens may worsen fatigue, falls, and cognitive decline.

2.

New imaging probe helps track prostate cancer and possibly treat it before resistance develops

3.

NIH research cuts leave cancer patient facing hard choice

4.

Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer

5.

PFS in Multiple Myeloma Is Improved by Daratumumab Added to Standard Therapy.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot